Axial Spondy Clinical Trials in Beijing, Beijing Municipality
4 recruitingBeijing, Beijing Municipality, China
Showing 1–4 of 4 trials
Recruiting
Multicenter Validation of the 2025 Classification Criteria for Axial Spondyloarthritis
Spondyloarthritis (SpA)Axial Spondyloarthritis (AxSpA)Chronic Back Pain
Chinese PLA General Hospital247 enrolled1 locationNCT07724847
Recruiting
Phase 2
A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)
Radiographic Axial Spondyloarthritis
Merck Sharp & Dohme LLC315 enrolled104 locationsNCT07133633
Recruiting
Phase 3
A Trial of SHR-1314 Injection in Adult Patients With Active Non-radiographic Axial Spondyloarthritis
Active Non-radiographic Axial Spondyloarthritis
Suzhou Suncadia Biopharmaceuticals Co., Ltd.380 enrolled1 locationNCT06860750
Recruiting
Phase 2
A Study to Evaluate 608 in Patients With Non- Radiographic Axial Spondyloarthritis (Nr-axSpA)
Axial Spondyloarthritis
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.180 enrolled6 locationsNCT06222671